Arlington, Va., November 19, 2025 — Timely by DrFirst, an end-to-end mobile platform that drives patient awareness and adherence for life science brands, has been named a Fierce Life Sciences Innovation Awards 2025 winner. The program, produced by Fierce Biotech and Fierce Pharma, showcases innovation that is driving improvements and transforming the life sciences industry. Timely was chosen as a winner for its potential to create efficiencies, engage patients, and revolutionize the industry.
With 25% of new prescriptions never filled and 50% of medications not taken as directed, traditional patient engagement efforts happen too late. Timely transforms the medication journey by connecting with providers and patients before problems occur.
Laizer Kornwasser, CEO of DrFirst, explained, “Traditional patient engagement for adherence happens too late to make a difference. Timely is unique because it’s proactive, relevant, and comes from the healthcare provider. For millions of patients, this creates a direct path to the treatments they need.”
Timely delivers key information into the provider’s electronic health record (EHR) prescribing workflows, including real-time assistance with specialty pharmacy selection, prior authorization insights, and patient copay and support resources. Moments after a prescription is written, patients receive automated text messages on behalf of their healthcare providers, offering educational content and savings programs, including direct enrollment pathways to patient support services. Personalized reminders at key milestones (pre-fill, post-fill, refills, and renewals) help patients start and stay on therapy.
“Technology is reshaping every corner of our industry—from AI to powerful new ways of harnessing data. This year’s winners represent the bold vision and innovation leading that charge. We’re thrilled to celebrate these pioneers and the momentum they’re creating. Congratulations to the 2025 winners,” says Rebecca Willumson, SVP and Publisher of Fierce Biotech and Fierce Pharma.
With an 85% patient engagement rate, up to 10% increase in prescription fills across all therapeutic classes, and less than 1% of patients opting out, Timely has earned the trust of 17 of the top 20 pharmaceutical companies.
About Timely by DrFirst
Timely by DrFirst is an end-to-end engagement platform that supports prescribers in their EHR workflow and engages patients with ongoing, personalized medication support from their trusted healthcare provider. Powered by DrFirst, which supports care for more than 100 million patients annually via the nation’s largest medication management network, Timely connects providers, pharmacies, and patients at critical moments throughout the medication journey—from prescribing to adherence. To learn more, visit Timely-Health.com.
About Fierce Biotech
Fierce Biotech is the biotech industry's daily monitor, providing the latest news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 300,000 top biotech professionals rely on Fierce Biotech for an insider briefing on the day's top stories. Signup is free here.
About Fierce Pharma
Biopharma is a fast-growing world where big ideas come along daily. Our readers rely on Fierce Pharma for the latest news, analysis and data on drugs and the companies that make them. Fierce Pharma covers the pharma waterfront, from late-stage drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations and regulation, M&A deals and beyond. Our aim is to analyze the day's news, showing readers not only what they need to know, but why they need to know it. Beyond the daily, the Fierce Pharma team produces special reports that take stock of the industry’s products and finances, and shed new light on industry trends.
Media Contact
Erin Jundef
Bospar Communications
Erin@Bospar.com
